MENU CLOSE

Our Mission:

Accelerating a Cure

for Multiple Myeloma

The Multiple Myeloma Research Foundation (MMRF) is the largest nonprofit in the world solely focused on accelerating a cure for each and every multiple myeloma patient.

We drive the development and delivery of next-generation therapies, leverage data to identify optimal and more personalized treatment approaches and empower myeloma patients and the broader community with information and resources to extend their lives.

The latest from The MMRF

MMRF Press Releases
Default blog news press Opna Bio Doses First Patient in Phase 1 Study in Multiple Myeloma with OPN-6602, an EP300/CBP Bromodomain Inhibitor
MMRF Press Releases
Multiple Myeloma Research Foundation (MMRF) Announces New Publication on CoMMpass Study in Nature Genetics Defining Distinct Subtypes of Multiple Myeloma and High-Risk Genetic Markers
MMRF Press Releases
Default blog news press Nammi Therapeutics, Inc. Completes Series B Round with Investment from MMRF’s Myeloma Investment Fund; Advances Clinical Development of Lead Program, QXL138AM
Scientific/Research Publications
Default blog news press Updates in MM From ASCO 2024 and EHA 2024
MMRF Press Releases
Default blog news press Myeloma Investment Fund Invests in Envisagenics, A.I.-Driven Biotechnology Company
Fundraising
MMRF Blog Post Thumbnail Image Meet Team Papa JJ (In honor of Douglas J.J. Peters), MMRF 2024 Walk/Run: Washington, D.C. Spirit of Hope Honoree
MMRF in the News
Default blog news press Statement on former MMRF Board Member and basketball legend Pat Williams
MMRF Press Releases
Default blog news press Myeloma Investment Fund Invests in Dynamic Cell Therapies to Help Fuel Novel CAR T-Cell Technologies
Scientific/Research Publications
Default blog news press Discovering new biology and vulnerabilities in high-risk disease from the MMRF CoMMpass study

Unprecedented Results

The MMRF’s patient-centered approach is changing cancer research. We’re problem solvers and innovators. Over the years, we’ve found original and creative ways to speed research, build collaborations, and break through institutional barriers that can slow progress.  Our unrelenting focus is on helping every patient find the right treatment.

$600M+

Raised for research

~100

Clinical trials

15+

Drugs brought to market

3X

Increase in life expectancy

About the MMRF

Our Work

Our work is guided by three core pillars: accelerate the development of novel therapies, drive optimal and more personalized treatment approaches, and empower patients and the myeloma community. Central to our mission is a commitment to advancing health equity so that all myeloma patients can benefit from the scientific and clinical advances we pursue.

Education Hub

Explore our publications, one-pagers, videos, podcasts, and much more to add to your knowledge of multiple myeloma treatment options and related topics. We have a collection of valuable resources to help you along every step of your multiple myeloma journey.

Myeloma Investment Fund® (MIF)

The Myeloma Investment Fund (MIF) accelerates new therapies for myeloma patients. The MIF identifies and invests in the most promising biotechnology companies transforming myeloma treatment.

Ways to Get Involved

Team for Cures

By joining the MMRF Team for Cures, you help accelerate a cure for each and every multiple myeloma patient.

Participants in the MMRF Team for Cures.
Patients participating in myeloma research.

Moving Myeloma Research Forward

Help us unlock vital answers in multiple myeloma research. Your involvement in research carries with it the potential to discover more effective treatments and save more lives.

MMRF Patient Toolkit
Download a comprehensive myeloma toolkit to guide you in your journey.

Get Your Free Toolkit